Brief: Morepen Laboratories March-Quarter Net Profit 119.1 Mln Rupees
12/05/2025 11:28
May 12 (Reuters) - Morepen Laboratories Ltd MORL.NS: MARCH-QUARTER NET PROFIT 119.1 MILLION RUPEES MARCH-QUARTER TOTAL INCOME 3.85 BILLION RUPEES EXECUTED ADDENDUM TO BUSINESS TRANSFER AGREEMENT WITH MOREPEN MEDIPATH Source text: ID:nBSE69Z82R Further company coverage: MORL.NS ((Reuters.Briefs@thomsonreuters.com;;))
Recent news on Morepen Laboratories
See all newsBrief: Morepen Laboratories Says High Court Quashes Notice Seeking Recovery Of 1.18 Billion Rupees
India's Morepen Laboratories gains on U.S. FDA submission for Sitagliptin tablets
Brief: Morepen Laboratories Submits First U.S. ANDA For Sitagliptin Tablets USP In Three Strengths
Brief: Morepen Laboratories Ltd June-Quarter Consol Net Profit 563.5 Million Rupees
India's Morepen Laboratories slips after quarterly profit fall